Design, development and control of a cosmetic body for skins with dermatitis.

  • Irene Flores Morales
    Universidad de Salamanca
  • Aranzazú Zarzuelo Castañeda
    Universidad de Salamanca drury[at]usal.es

Abstract

Nowadays, people are aware of the need to carry out the necessary skin care to prevent a new outbreak due to the increase in cases of atopic dermatitis and the high prevalence of adverse effects resulting from the prescribed treatment. The pharmacist, as a healthcare professional, can offer customized products through masterful formulation and cosmetics. This work collects the design and development of a base cosmetic products, which can undergo different modifications to individualize and adapt the treatment to the needs of each patient, and the stability test that is carried out during the 3 months after its elaboration. Besides, it collects the results obtained after its application in several patients and a guide that includes measures of maintenance to avoid the appearance of the characteristic symptomatology of dermatitis.
  • Referencias
  • Cómo citar
  • Del mismo autor
  • Métricas
Boguniewicz M, Leung D. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunological Reviews. 2011; 242 (1): 233-246.
Bonet R. Dermatitis atópica. Elsevier.es. Offarm. 2001; 20(10): 79-87.
Brown D, Dattner A. Phytotherapeutic Approaches to Common Dermatologic Conditions. Archives of Dermatology. 1998; 134 (11): 1401-1404.
Castrillón Rivera LA, Palma Ramos A, Padilla Desgarennes C. Péptidos antimicrobianos: antibióticos naturales de la piel. Dermatología Rev Mex. 2007; 51(2): 57-679.
Danby S. Biological Variation in Skin Barrier Function: From A (Atopic Dermatitis) to X (Xerosis). Current Problems in Dermatology. 2016; 49: 47-60.
Deters A1, Dauer A, Schnet E, Fartash M, Hensel A. High molecular compounds (polysaccharides and proanthocyanidins) from Hamamelis virginiana bark: influence on human skin keratinocyte proliferation and differentiation and influence on irritated skin. Phytochemistry. 2001; 58 (6): 949-58.
Escovar Langebeck X, Chalela Mantilla J. PÉPTIDOS ANTIMICROBIANOS CUTÁNEOS. Dermatol Peru. 2004; 14(1): 40-43.
Ferna?ndez Ferna?ndez M. Cosme?tica y dermofarmacia. Alcala? La Real (Jae?n): Formacio?n Alcala?; 2005; 59-63.
Guerra Tapia A, Gonza?lez-Guerra E. Dermatitis ato?pica. 1st ed. Madrid: Saned; 2007.
Marti?n Mateos M. Gui?a de tratamiento de la dermatitis ato?pica en el nin?o. Documento de Consenso Grupo de Expertos. Majadahonda, Madrid: Ergo?n; 2011.
Méndez-Cabeza Velázquez J, Alache Zúñiga H, Cerrada Cerrada E. Manejo de la dermatitis atópica en Atención Primaria. MEDIFAM. 2003; 13 (2): 75-84.
Ng J, Liew H, Ang S. Use of emollients in atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 2014; 29(5): 854-85.
Ridao i Redondo M. Dermatitis atópica. Pediatr Integral [Internet]. 2012 [Consultado el 9 de Enero de 2017]; 16(3): 213-221. Disponible en: http://www.pediatriaintegral.es/numeros-anteriores/publicacion-2012-04/dermatitis-atopica/
Simpson E. Atopic dermatitis: a review of topical treatment options. Current Medical Research and Opinion. 2010; 26 (3): 633-640.
Umbert P, Llambi? Mateos F. La Formulacio?n en la dermatologi?a del 2010. 1ª ed. Barcelona: Acofarma; 2008; 137-147.
Flores Morales, I., & Zarzuelo Castañeda, A. (2018). Design, development and control of a cosmetic body for skins with dermatitis. FarmaJournal, 3(1), 57–66. Retrieved from https://revistas.usal.es/cinco/index.php/2445-1355/article/view/17454

Downloads

Download data is not yet available.

Author Biography

Aranzazú Zarzuelo Castañeda

,
Universidad de Salamanca
Departamento de Ciencias Farmacéuticas. Área de Farmacia y Tecnología Farmacéutica. Campus Miguel de Unamuno. Calle Lic. Méndez Nieto, s/n, 37007 Salamanca
+